Your search returned 4 results.

Results
	1.	Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. [electronic resource] by Formann, E Jessner, W Bennett, L Ferenci, P Producer: 20030910 In: Journal of viral hepatitis vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection. [electronic resource] by Jessner, W Watkins-Riedel, T Müller, C Formann, E Gschwantler, M Ferenci, P Producer: 20080122 In: Journal of viral hepatitis vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy. [electronic resource] by Formann, E Steindl-Munda, P Hofer, H Jessner, W Bergholz, U Gurguta, C Ferenci, P Producer: 20060629 In: Alimentary pharmacology & therapeutics vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Short- and long-term effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C. [electronic resource] by Homoncik, M Ferlitsch, A Ferenci, P Formann, E Jilma, B Gangl, A Panzer, S Peck-Radosavljevic, M Producer: 20050419 In: Alimentary pharmacology & therapeutics vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)